XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED CONDENSED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Restricted Stock
Options and Restricted Stock
Common Stock
Common Stock
Options and Restricted Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Restricted Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2020         95.6               1.4
Balance at beginning of period at Dec. 31, 2020 $ 675.6       $ 1.0   $ 346.9     $ 360.2   $ (6.5) $ (26.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Common stock issued during period (in shares)         89.8 0.2              
Common stock issued during period 2,650.2     $ 0.0 $ 0.9   2,649.3            
Share-based compensation 4.6   $ 33.1       4.6   $ 33.1        
Acquisition of treasury stock (in shares)                         (0.4)
Acquisition of treasury stock (12.5)                       $ (12.5)
Exercise of stock options 0.2           (0.5)           $ 0.7
Compensatory awards released from restriction (in shares)                         0.9
Compensatory awards released from restriction 0.0           (16.6)           $ 16.6
Equity adjustment from foreign currency translation (16.2)                     (16.2)  
Change in fair value of derivative instruments, net of tax 5.3                     5.3  
Net income 272.5                 272.5      
Balance at end of period (in shares) at Mar. 31, 2021         185.6               0.9
Balance at end of period at Mar. 31, 2021 3,612.8       $ 1.9   3,016.8     632.7   (17.4) $ (21.2)
Balance at beginning of period (in shares) at Dec. 31, 2020         95.6               1.4
Balance at beginning of period at Dec. 31, 2020 675.6       $ 1.0   346.9     360.2   (6.5) $ (26.0)
Balance at end of period (in shares) at Dec. 31, 2021         186.2               1.0
Balance at end of period at Dec. 31, 2021 $ 3,682.9 $ (44.7)     $ 1.9   3,051.6 $ (57.1)   682.2 $ 12.4 (27.3) $ (25.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                        
Share-based compensation $ 13.8           13.8            
Acquisition of treasury stock (in shares)                         (1.5)
Acquisition of treasury stock (34.2)                       $ (34.2)
Compensatory awards released from restriction (in shares)                         1.0
Compensatory awards released from restriction 0.0           (24.0)           $ 24.0
Equity adjustment from foreign currency translation (13.4)                     (13.4)  
Change in fair value of derivative instruments, net of tax 9.4                     9.4  
Net income 86.7                 86.7      
Balance at end of period (in shares) at Mar. 31, 2022         186.2               1.5
Balance at end of period at Mar. 31, 2022 $ 3,700.5       $ 1.9   $ 2,984.3     $ 781.3   $ (31.3) $ (35.7)